Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab

被引：0
|
作者：
Chaudhary, Varun [1 ]
Brent, Michael [2 ]
Lam, Wai-Ching [2 ]
Devenyi, Robert [2 ]
Teichman, Joshua [1 ]
Mak, Michael Ying-Kit [2 ]
Kaur, Harneel [1 ]
Barbosa, Joshua [1 ]
Carter, Ronald [4 ]
Farrokhyar, Forough [3 ]
机构：
[1] McMaster Univ, Hamilton Reg Eye Inst, Dept Surg, Div Ophthalmol, Hamilton, ON, Canada
[2] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada
[3] McMaster Univ, Dept Surg, Hamilton, ON, Canada
[4] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
来源：
OPHTHALMOLOGICA | 2018年 / 239卷 / 04期
关键词：
D O I：
10.1159/000481178
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [31] A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
    de Motta, Laura Lores
    Van Asten, Freekje
    Muether, Philipp S.
    Smailhodzic, Dzenita
    Chen, John C.
    Koenekoop, Robert K.
    Fauser, Sascha
    Hoyng, Carel C. B.
    Den Hollander, Anneke I.
    de Jong, Eiko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [32] Genetic and modifiable risk factors for age-related macular degeneration
    Wang, Jiei In
    EXPERT REVIEW OF OPHTHALMOLOGY, 2006, 1 (02) : 181 - 194
  • [33] Genetic factors associated with the development of age-related macular degeneration
    Sergejeva, Olga
    Botov, Roman
    Liutkeviciene, Rasa
    Kriauciuniene, Loresa
    MEDICINA-LITHUANIA, 2016, 52 (02): : 79 - 88
  • [34] Genetic cardiovascular risk factors and age-related macular degeneration
    Haas, Paulina
    Aggermann, Tina
    Steindl, Kerstin
    Krugluger, Walter
    Puehringer, Helene
    Oberkanins, Christian
    Frantal, Sophie
    Binder, Susanne
    ACTA OPHTHALMOLOGICA, 2011, 89 (04) : 335 - 338
  • [35] Treatment of wet age-related macular degeneration by ranibizumab in "real life" in France: treatment behaviours and associated visual outcome
    Souied, Eric H.
    Cohen, Salomon-Yves
    de Pouvourville, Gerard
    Dupeyron, Gerard
    Latour, Elisabeth
    Ponthieux, Anne
    Weber, Michel
    ACTA OPHTHALMOLOGICA, 2015, 93 (02) : E179 - E180
  • [36] Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration
    Regillo, Carl D.
    Busbee, Brandon G.
    Ho, Allen C.
    Ding, Beiying
    Haskova, Zdenka
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 160 (05) : 1014 - 1023
  • [37] The Prevalence of Age-Related Macular Degeneration and Associated Risk Factors
    Klein, Ronald
    Cruickshanks, Karen J.
    Nash, Scott D.
    Krantz, Elizabeth M.
    Javier Nieto, F.
    Huang, Guan H.
    Pankow, James S.
    Klein, Barbara E. K.
    ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (06) : 750 - 758
  • [38] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [39] Genetic factors of age-related macular degeneration
    Tuo, JS
    Bojanowski, CM
    Chan, CC
    PROGRESS IN RETINAL AND EYE RESEARCH, 2004, 23 (02) : 229 - 249
  • [40] Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, Helen
    Abrams, Paris
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 1850 - 1861
12345